CAMP4 Therapeutics Corporation Common Stock (CAMP)

About CAMP

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Mara…

Employees

48

Website

www.camp4tx.com/

Fundamentals

1-day range

$4.04$4.3

Market cap

$218.61M

P/E (trailing)

—

P/E (forward)

-5.22

EPS (trailing)

$-2.24

Dividend yield

—

Beta

-25.05

Avg. volume

253.4K

Forecasts

6 analyst ratings

Latest news

• Piper Sandler Reiterates Overweight on Camp4 Therapeutics, Raises Price Target to $15
  benzinga · 8/14/2026
• Piper Sandler Reiterates Overweight on Camp4 Therapeutics, Raises Price Target to $15
  Benzinga · 8/14/2026
• CAMP4 Therapeutics Corporation (CAMP) Reports Q2 Loss, Tops Revenue Estimates
  Yahoo · 8/13/2026
• CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
  Yahoo · 8/13/2026
• Camp4 Therapeutics Q2 EPS $(0.58) Misses $(0.21) Estimate, Sales $1.779M Miss $1.897M Estimate
  Benzinga · 8/13/2026
• Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates
  Yahoo · 8/6/2026
• MannKind (MNKD) Reports Q2 Loss, Beats Revenue Estimates
  Yahoo · 8/5/2026
• CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
  Yahoo · 8/4/2026
• CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates
  Yahoo · 8/3/2026

• Andrew J. Schwab · August 24, 2026 · Sale

  10 @ $4.5
• Yuri Maricich · August 3, 2026 · Buy

  6.6K @ $1.65
• Kelly Gold · August 3, 2026 · Buy

  6.6K @ $1.65
• Josh Mandel-Brehm · August 3, 2026 · Buy

  6.6K @ $1.65
• 5AM Partners VI, LLC · August 3, 2026 · Buy

  3.18M @ $1.53
• Andrew J. Schwab · August 3, 2026 · Grant

  3.18M @ $1.53
• Richard A. Young · August 3, 2026 · Buy

  16.4K @ $1.65
• Murray Stewart · June 10, 2026 · Grant

  28.0K
• Andrew J. Schwab · June 10, 2026 · Grant

  28.0K
• Amir Nashat · June 10, 2026 · Grant

  28.0K
• Richard A. Young · June 10, 2026 · Grant

  28.0K
• Holtzman Steven H · June 10, 2026 · Grant

  28.0K
• WILLIAMS DOUGLAS E · June 10, 2026 · Grant

  28.0K
• Tardiff Daniel · April 1, 2026 · Grant

  170.0K
• Kelly Gold · April 1, 2026 · Grant

  215.0K

Institutional Ownership

March 31, 2026

Total shares held

39.59M

Total value held

$174.53M

Institutional holders

45